Mechanistic and Molecular Study of the Process of Metastatic Dissemination in Colorectal Cancer
NCT03613194 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2018-08-03
Summary
To confirm the role of the collective dissemination in the mechanisms of tumoral invasion of colorectal cancers
Conditions
Interventions
- PROCEDURE
-
Sampling
After inclusion in the study, eligible patients having hepatic metastases and/or péritonéales of a colorectal cancer considered as resecables will have biological and tissue samples. The samples will be carried out at the time of the surgical gesture envisaged under general anaesthesia and will concern: * Tumoral material: primitive tumour (if available), hepatic metastases and/or peritoneal * Peritoneal liquid * none tumoral peritoneum * Portal blood * Peripheral blood * Cellulo-lymphatic material The necessary time to carry out the whole of these samples is estimated at 10-15 minutes maximum. In the event of complex situations being able to complicate the surgical gesture initially envisaged or to increase by them morbidity, one or more these samples will not be carried out. This decision will be made at the discretion of the investigator.
Sponsors & Collaborators
-
Gustave Roussy, Cancer Campus, Grand Paris
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-25
- Primary Completion
- 2020-06-30
- Completion
- 2020-06-30
Countries
- France
Study Locations
More Related Trials
-
Identification of New Patient Stratification Tools in MSS RAS mt mCRC
NCT03699111 ·Status: COMPLETED
-
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
NCT04607421 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung
NCT00557102 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer
NCT00559676 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Estimate Overall Survival in Patients Receiving Best Supportive Care for Treatment-Resistant, Metastatic Colorectal Carcinoma
NCT03096899 ·Status: WITHDRAWN
-
Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer
NCT02254941 ·Status: UNKNOWN
-
Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery
NCT01097265 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants
NCT00138060 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Therapeutic Response and Survival of Patients with Metastatic Colorectal Cancer (stage IV) and Treated According to the Guidelines of a Chemosensitivity Test, Oncogramme® (ONCOGRAM)
NCT03133273 ·Status: COMPLETED ·Phase: NA
-
An Observational Study of Bevacizumab in Combination With 5-FU-Based Chemotherapy in Chinese Participants With Metastatic Colorectal Cancer
NCT01319877 ·Status: COMPLETED
-
Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
NCT00467142 ·Status: COMPLETED ·Phase: PHASE2
-
CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer
NCT00932724 ·Status: TERMINATED ·Phase: PHASE2
-
Individualization of Dosage of Irinotecan in the FOLFIRI According to the Genetic Polymorphism of UGT1A1 in the First Line Treatment of Metastatic Colorectal Cancer
NCT01963182 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases
NCT03599752 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Rechallenge of Cetuximab Combined With Irinotecan as Third-line Chemotherapy in Patients With Metastatic Colorectal Cancer - Phase II Study
NCT02316496 ·Status: TERMINATED ·Phase: PHASE2
-
The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients
NCT04397575 ·Status: COMPLETED
-
Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies
NCT01607957 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Trial With Dendritic Cells in Patients With Metastatic Colorectal Cancer
NCT01413295 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal Cancer
NCT01486251 ·Status: COMPLETED ·Phase: NA
-
Determination of Microbiological Factors Associated With Poor Response to Neoadjuvant Treatment in Rectal Cancers
NCT04103567 ·Status: RECRUITING ·Phase: NA
-
A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy
NCT02743221 ·Status: COMPLETED ·Phase: PHASE2
-
Cetuximab as Salvage Therapy in Patients With Neo Wild-type RAS/RAF Metastatic Colorectal Cancer With Liver Metastases.
NCT04189055 ·Status: UNKNOWN ·Phase: PHASE2
-
Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer
NCT02090101 ·Status: COMPLETED ·Phase: PHASE2
-
Image Guided Treatment Optimization With Cetuximab for Patients With Metastatic Colorectal Cancer
NCT02117466 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma
NCT01208194 ·Status: COMPLETED ·Phase: PHASE2